Phage Protein Blocks Bacterial Lipid Transporter
Researchers at Nara Institute of Science and Technology mapped how a bacteriophage protein halts the bacterial protein MurJ from moving lipids.
Updated on Nov. 10, 2026 in Life Sciences

Researchers at Nara Institute of Science and Technology determined how the bacteriophage protein SglPP7 inhibits the bacterial protein MurJ. The findings were published in PLOS Biology on October 27, 2026.
Why it matters
Drug-resistant bacteria are becoming more common worldwide, creating a major public health challenge that requires new ways to eliminate bacteria. Understanding how phage proteins disable a key bacterial transporter could inform the design of new antibacterial approaches.
The findings rest on cryo-electron microscopy structures of the MurJ-SglPP7 complex, supported by targeted protein mutation experiments, bacterial cell lysis tests, and computer simulations. The extraction does not report measured effect sizes, and it remains unstated how the inhibition performs beyond the laboratory setting.
The players
Hidetaka Kohga
Kohga is an assistant professor at Nara Institute of Science and Technology who led the research team behind the study.
Nara Institute of Science and Technology
Nara Institute of Science and Technology is a Japanese research university in Nara that issued the press release on the study.
The details
SglPP7 lies along a lipid-binding groove in MurJ and inserts its short C-terminal tail into a deep internal cavity, stabilizing the protein in an outward-facing conformation. This blocks MurJ from completing the structural changes needed to transport lipid, and the researchers found SglPP7, LysM, and SglCJ3 stabilize a similar conformation despite binding in different ways.
Timeline
October 27, 2026: Study published in PLOS Biology.
November 9, 2026: Nara Institute of Science and Technology issued a press release.
The Big Picture
MurJ functions as the lipid II flippase in bacterial cell wall synthesis, and this study extends that picture by showing how a bacteriophage protein locks it in an outward-facing state. Structural convergence among SglPP7, LysM, and SglCJ3 suggests phage proteins may share a common strategy for disabling this transporter.
Findings like these could eventually inform new antibacterial agents aimed at drug-resistant infections, though the extraction describes these as possibilities rather than near-term products. Drug developers and researchers would need to test whether the mechanism can be targeted in practice before any treatment reaches patients.
The takeaway
The study shows that bacteriophage proteins can disable bacterial machinery through precise structural contact, offering a model for designing future antibacterial strategies. Its significance will depend on whether follow-up work translates these structural insights into testable drug candidates.
Further reading
Explore more research in Life Sciences for context on how microbial proteins shape bacterial biology.
More information
Read the PLOS Biology study on phage protein SglPP7 for the full structural data.



